查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1974091

人工智慧增强型磁振造影系统市场：按组件、磁振造影系统类型、应用和最终用户划分－2026-2032年全球预测

AI-Enhanced MRI System Market by Component, MRI System Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，人工智慧增强型 MRI 系统市场价值将达到 102.7 亿美元，到 2026 年将成长至 110 亿美元，到 2032 年将达到 172.4 亿美元，复合年增长率为 7.67%。

主要市场统计数据
基准年 2025 102.7亿美元
预计年份：2026年 110亿美元
预测年份 2032 172.4亿美元
复合年增长率 (%) 7.67%

本次演讲将清晰简洁地介绍一个系统，该系统透过引入人工智慧增强磁振造影技术，将影像物理学、机器学习和临床工作流程结合，重新定义了诊断效果和操作效率。

人工智慧增强型磁振造影（AI Enhanced MRI）融合了先进的影像物理学、机器学习和系统工程技术，正在革新临床医生获取、解读和应对诊断资讯的方式。深度学习驱动的重建、降噪和自动量化技术的创新，透过提高影像清晰度和缩短撷取时间，扩展了临床工作流程，并为以患者为中心的通讯协定创造了新的机会。这些技术并非独立运行，而是与资料管理平台、云端运算服务和医院资讯系统集成，从而实现模型优化、品质保证和结果追踪的持续循环。

演算法的突破、硬体的小型化以及联邦数据方法的进步，正在从根本上重塑 MRI 的功能、工作流程和医疗保健服务模式。

磁振造影（MRI）技术正经历着变革性的转变，这主要得益于演算法能力的提升、硬体的创新以及新型医疗服务模式的进步，这些因素共同重新定义了人们对影像品质、速度和临床效用的期望。基于深度学习的重建技术能够缩短采集时间，并实现低剂量或造影剂通讯协定，从而扩大了MRI诊断的适用人群。同时，磁铁和梯度设计的改进正在降低系统面积和能耗，使得在传统医院环境之外部署MRI设备变得越来越可行。

本研究评估了美国在 2025 年实施的关税措施对 MRI 供应链、筹资策略以及长期供应商和临床伙伴关係的策略性连锁反应。

美国将于2025年实施的新关税措施，为依赖国际采购零件和子系统的供应商、系统整合商和医疗保健机构带来了复杂的商业环境。关税带来的成本压力正在影响筹资策略，促使相关人员寻求供应商多元化，考虑总到岸成本，并重新评估库存政策。为此，製造商和系统整合商正在加快本地化进程，重组全球供应链，并探索替代零件采购管道，以维持价格稳定和交货可靠性。

将组件架构、系统外形规格、临床应用和最终用户需求与策略性产品开发和商业化决策连结起来的综合細項分析。

透过捕捉细微差异的細項分析，可以揭示不同组件、系统类型、应用和最终用户之间独特的技术和商业性动态，这些动态会影响产品设计、市场进入策略和临床部署路径。依组件划分，市场分析分为硬体、服务和软体。硬体进一步细分为梯度系统和磁体系统；服务细分为安装服务和维护服务；软体细分为资料管理解决方案和影像软体。这种组件层面的观点突显了研发投资趋势，这些趋势优先考虑的是提高磁铁和梯度子系统的物理性能，或是开发支援下游临床工作流程的云端资料管理和演算法功能。

针对美洲、欧洲、中东、非洲和亚太地区的区域特定趋势和战略意义，探讨其对采用、采购和伙伴关係策略的影响。

区域趋势源自于基础设施、报销框架、管理体制和产业政策的差异，这些差异影响着人工智慧增强型磁振造影解决方案的采纳路径和竞争定位。在美洲，创新丛集和一体化医疗保健系统创造了有利于试点部署和企业级扩展先进成像应用的环境。临床使用者往往优先考虑基于结果的证据和能够提高临床效率和诊断准确性的价值提案。因此，供应商通常会与学术机构和大型医院网路合作，进行多中心临床检验，以获得临床医生的支援。

现有的 OEM 製造商、人工智慧创新者和系统整合商正在透过检验、伙伴关係和服务模式来脱颖而出，从而在不断发展的 MRI 生态系统中建立竞争优势。

人工智慧增强型磁振造影领域的竞争格局呈现出多元化的态势，既有成熟的成像设备製造商，也有新兴的人工智慧专家和系统整合商，各方都在技术研发和商业化方面发挥各自的优势。现有设备製造商正利用其在磁铁和梯度电路设计方面的深厚专业知识、全球服务网路以及现有的临床关係，将人工智慧增强功能整合到下一代平台中。这些成熟企业往往专注于长期业务收益模式，旨在实现无缝整合、跨市场监管合规以及维护已部署设备的效能。

为技术开发人员、临床领导者和采购团队提供切实可行的策略建议，以加速人工智慧驱动的 MRI 创新技术的应用、管理风险并创造价值。

产业领导者应推动一系列合作倡议，将技术开发、临床检验和商业化紧密结合，从而从人工智慧增强型磁振造影创新中创造价值。首先，应优先考虑模组化架构，将硬体升级与软体/演算法改进分离，从而实现持续改进而无需迭代式资本投入。同时，应建立一套严谨的临床评估流程，包括多中心合作研究和同行评审出版物，以增强临床医生的信心并获得支付方的认可。

采用严谨的混合调查方法，结合临床医师访谈、监管分析、专利格局分析和证据三角验证，指南策略决策，并找出证据不足的领域。

本研究整合了结构化调查方法所获得的洞见，该方法结合了与临床和技术相关人员的定性对话、对科学文献和监管申请文件的系统性二手研究，以及透过技术和专利状态分析进行的三角检验。主要研究包括对临床医生、放射科医生、医院采购负责人、系统整合商和研发经理的详细访谈，以确定实际应用中的挑战、临床优先事项和采购考虑。基于这些对话，我们对用例进行了优先排序，并制定了检验演算法效能和服务预期所需的标准。

简洁扼要的结论整合了成功大规模部署人工智慧驱动的 MRI 解决方案所需的基本技术、临床和操作要求。

总而言之，人工智慧增强型磁振造影技术正从概念验证计划阶段迈向整合临床工具阶段，从而改善诊断工作流程、提供量化支援并实现以患者为中心的成像通讯协定。重建技术、演算法分析和系统设计的技术进步正与不断发展的医疗服务模式相融合，从而创造显着的临床和营运效益。同时，贸易政策、供应链重组和不断变化的监管要求等结构性压力也在影响解决方案的设计、采购和部署方式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：人工智慧增强型磁振造影系统市场：按组件划分

  • 硬体
    • 梯度系统
    • 磁性系统
  • 服务
    • 安装服务
    • 维护服务
  • 软体
    • 资料管理解决方案
    • 影像处理软体

第九章：依MRI系统类型分類的AI增强型MRI系统市场

  • 封闭式磁振造影
  • 开放式磁振造影

第十章：人工智慧增强型磁振造影系统市场：按应用领域划分

  • 临床试验
  • 诊断影像
    • 心臟病学
    • 神经病学
    • 肿瘤学
  • 研究

第十一章：人工智慧增强型磁振造影系统市场：依最终用户划分

  • 诊断中心
  • 医院
  • 私人执业放射科医生
  • 研究机构

第十二章：人工智慧增强型磁振造影系统市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：人工智慧增强型磁振造影系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：人工智慧增强型磁振造影系统市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国人工智慧增强型磁振造影系统市场

第十六章：中国人工智慧增强型磁振造影系统市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arterys Inc.
  • Blackford Analysis LTD
  • Canon Medical Systems Corporation
  • Cerebriu A/S
  • CityClinic Vietnam Limited
  • CureMetrix
  • EnvoyAI Inc.
  • Esaote SpA
  • Ezra AI, Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Hitachi Medical Corporation
  • Hyperfine, Inc.
  • Koninklijke Philips NV,
  • Medic Vision Imaging Solutions
  • Neusoft Medical Systems
  • Nuance Communications
  • Perspectum Ltd
  • Samsung Electronics Co.Ltd
  • Siemens Healthineers AG
  • Subtle Medical, Inc.
  • United Imaging Healthcare Co., Ltd
  • Volpara Solutions
  • Zebra Medical Vision, Inc.
Product Code: MRR-5D340F440B73

The AI-Enhanced MRI System Market was valued at USD 10.27 billion in 2025 and is projected to grow to USD 11.00 billion in 2026, with a CAGR of 7.67%, reaching USD 17.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.27 billion
Estimated Year [2026] USD 11.00 billion
Forecast Year [2032] USD 17.24 billion
CAGR (%) 7.67%

A clear, concise introduction to how AI-enhanced MRI is converging imaging physics, machine learning, and clinical workflows to redefine diagnostic efficacy and operational efficiency

AI-enhanced MRI represents a convergence of advanced imaging physics, machine learning, and systems engineering that is reshaping how clinicians capture, interpret, and act on diagnostic information. Innovations in deep learning-powered reconstruction, noise reduction, and automated quantification are improving image clarity and shortening acquisition times, thereby expanding clinical workflows and creating new opportunities for patient-centric protocols. These technologies do not operate in isolation; they integrate with data management platforms, cloud compute services, and hospital information systems to enable a continuous cycle of model refinement, quality assurance, and outcome tracking.

Clinicians and health system leaders are increasingly motivated by the potential for AI to enhance diagnostic confidence, reduce repeat scans, and enable earlier interventions. At the same time, engineering teams focus on algorithm robustness, generalizability across scanner vendors, and compatibility with existing sequences and coils. Regulatory agencies have elevated expectations for clinical validation, traceability, and post-market surveillance, which in turn drives vendors to adopt rigorous evidence-generation processes. Consequently, successful adoption now requires cross-functional coordination among clinical champions, IT leaders, procurement, and vendor partners, who must all align on clinical use cases, deployment workflows, and measurable outcomes.

Looking forward, integration of AI into MRI workflows will prioritize patient throughput, reproducibility, and clinician interpretability. As a result, leaders who invest early in interoperable architectures, clinician training, and transparent model governance will be better positioned to translate technological promise into demonstrable clinical value. Transitional strategies that combine pilot implementations with iterative scale-up will reduce operational friction and accelerate the institutional learning necessary for broader adoption.

How algorithmic breakthroughs, hardware miniaturization, and federated data approaches are collectively reshaping MRI capabilities, workflows, and care delivery models

The landscape for MRI technology is undergoing transformative shifts driven by advances in algorithmic capability, hardware innovation, and new care delivery models that together redefine expectations for image quality, speed, and clinical utility. Deep learning-based reconstruction methods are shortening acquisition windows and enabling lower-dose or contrast-free protocols, which in turn expand the range of patient populations that can benefit from MRI diagnostics. Simultaneously, improvements in magnet and gradient designs are reducing system footprints and energy consumption, making deployment outside traditional hospital environments increasingly feasible.

Interoperability and data portability have become central as federated learning approaches emerge to train robust models across geographically dispersed datasets without exposing patient-level data. This shift toward distributed intelligence supports multi-center validation and reduces institutional bias, thereby improving clinical generalizability. Cloud-enabled orchestration is also changing how image processing and analytics are delivered: centralized compute resources enable rapid model updates, while edge-enabled inference preserves workflow speed and reduces latency in clinical settings.

Workforce transformation accompanies these technological changes. Radiologists and technologists are adopting decision support tools that highlight abnormalities, quantify tissue properties, and automate routine measurements, which frees time for complex interpretation and multidisciplinary collaboration. Consequently, service models are evolving to emphasize software maintenance, algorithm lifecycle management, and continuous clinical education. Partnerships between OEMs, AI specialists, and health systems are emerging as the dominant route to accelerate commercialization, with an emphasis on shared data assets, joint validation studies, and integrated go-to-clinic strategies.

Assessing the strategic ripple effects of United States tariff measures in 2025 on MRI supply chains, procurement strategies, and long-term vendor and clinical partnerships

The introduction of new tariff measures in the United States during 2025 is creating a complex operating environment for suppliers, integrators, and healthcare providers that rely on internationally sourced components and subsystems. Tariff-driven cost pressure has influenced procurement strategies, prompting stakeholders to re-evaluate supplier diversification, total landed cost considerations, and inventory policies. In response, manufacturers and system integrators are accelerating localization efforts, reconfiguring global supply chains, and considering alternative component sourcing to preserve pricing stability and delivery reliability.

These adjustments extend beyond hardware procurement to affect software licensing and service arrangements. Because many AI-enhanced MRI solutions combine hardware, embedded software, and cloud-based analytics, tariffs that target hardware components can have downstream implications for bundled service pricing and maintenance contracts. Organizations are therefore renegotiating long-term service agreements to account for evolving cost structures and to protect predictability in lifecycle spending. Moreover, regulatory timelines and customs processes have become more nuanced factors in vendor selection, as delays in customs clearance or import approvals can disrupt deployment schedules and clinical rollout plans.

To mitigate exposure, stakeholders are adopting strategic levers that include onshoring critical assembly tasks, establishing regional repair hubs to reduce cross-border movement of parts, and leveraging contractual mechanisms that share tariff risk across the supply chain. In parallel, alliances with local manufacturing partners and targeted investments in domestic capabilities help preserve continuity for clinical customers. These responses underline that tariffs are not merely a cost issue but a catalyst for longer-term structural changes in how MRI ecosystems are designed, produced, and supported.

Comprehensive segmentation insights that connect component architecture, system form factors, clinical applications, and end-user requirements to strategic product and commercialization decisions

A nuanced segmentation analysis reveals distinct technological and commercial dynamics across components, system types, applications, and end users that affect product design, go-to-market strategy, and clinical adoption pathways. Based on Component, the market is studied across Hardware, Services, and Software; the Hardware is further studied across Gradient Systems and Magnet Systems; the Services is further studied across Installation Services and Maintenance Services; the Software is further studied across Data Management Solutions and Imaging Software. This component-level view highlights how R&D investments prioritize either physical performance improvements for magnet and gradient subsystems, or cloud-enabled data management and algorithmic capabilities that deliver downstream clinical workflows.

Based on MRI System Type, the market is studied across Closed MRI and Open MRI, and each form factor presents distinct clinical and operational trade-offs. Closed systems continue to offer higher-field performance and advanced sequences suitable for complex neuro and oncologic imaging, whereas open systems address accessibility, patient comfort, and point-of-care scenarios where ease of use and throughput are paramount. Device architects and clinical teams must therefore balance field strength, coil design, and workflow integration against patient population needs.

Based on Application, the market is studied across Clinical Trials, Diagnostic Imaging, and Research; the Diagnostic Imaging is further studied across Cardiology, Neurology, and Oncology. Clinical trials and research environments prioritize reproducibility, standardized protocols, and quantitative endpoints, while diagnostic imaging settings demand workflow efficiency, rapid turnaround, and decision-support tools that integrate with picture archiving and communication systems. Within diagnostic imaging, cardiology applications emphasize functional and tissue characterization, neurology focuses on advanced structural and functional mapping, and oncology requires high-resolution and multiparametric assessments for staging and treatment monitoring.

Based on End User, the market is studied across Diagnostic Centers, Hospitals, Individual Radiologists, and Research Institutes, and each end user group navigates distinct procurement cycles, budget constraints, and clinical expectations. Diagnostic centers prioritize throughput and cost-effectiveness, hospitals balance specialty service lines with integrated IT investments, individual radiologists may seek portable or software-augmented tools to extend capabilities, and research institutes favor modular, extensible platforms that support novel sequences and experimental workflows. Taken together, these segmentation insights inform product roadmaps, validation priorities, and tailored commercial models that align technical capabilities with specific clinical use cases and buyer behaviors.

Region-specific dynamics and strategic implications for adoption, procurement, and partnership strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption pathways and competitive positioning for AI-enhanced MRI solutions, driven by differences in infrastructure, reimbursement frameworks, regulatory regimes, and industrial policy. In the Americas, innovation clusters and integrated health systems create fertile environments for piloting advanced imaging applications and scaling enterprise-wide deployments; clinical adopters often emphasize outcomes-based evidence and value propositions tied to throughput and diagnostic yield. As a result, vendors commonly partner with academic centers and large hospital networks to generate multicenter clinical validation and clinician endorsement.

In Europe, Middle East & Africa, regulatory harmonization efforts and public-sector procurement mechanisms inform long procurement cycles and centralized purchasing models, while national healthcare priorities drive demand for cost-effective, energy-efficient solutions. This region also demonstrates a strong focus on data privacy, interoperability, and cross-border collaboration, which encourages federated validation approaches and standards-based integrations. Vendors navigating this region benefit from clear regulatory strategies and robust post-market surveillance frameworks that align with public payer expectations.

In Asia-Pacific, rapid capacity expansion, diverse regulatory pathways, and growing local manufacturing capabilities create a dynamic ecosystem where adoption can accelerate quickly when clinical evidence and cost profiles align. Emerging markets within the region prioritize scalable, resilient solutions that tolerate infrastructure variability and support remote diagnostics. At the same time, national initiatives to localize medical device production and increase research capacity are reshaping supply chains and creating opportunities for regional partnerships. Across all regions, geopolitical forces and trade measures further influence sourcing decisions, highlighting the importance of flexible manufacturing footprints and region-specific go-to-market approaches.

How incumbent OEMs, AI innovators, and systems integrators are differentiating through validation, partnerships, and service models to win in the evolving MRI ecosystem

Competitive dynamics in the AI-enhanced MRI space center on a mix of established imaging OEMs, emerging AI specialists, and systems integrators that bring distinct strengths to technological development and commercialization. Established device manufacturers leverage deep expertise in magnet and gradient engineering, global service networks, and existing clinical relationships to embed AI-enhanced features into next-generation platforms. These incumbents tend to focus on seamless integration, regulatory compliance across markets, and long-term service revenue models that maintain installed-base performance.

By contrast, AI specialists and software-first entrants prioritize rapid iteration, cloud-based delivery models, and clinical partnerships to validate algorithms across diverse patient cohorts. Their competitive advantage often rests on proprietary training datasets, algorithmic differentiation, and agile product development cycles. Systems integrators and value-added resellers play a critical role in assembling multi-vendor solutions that address institutional IT constraints and workflow preferences, particularly in complex hospital environments.

Successful players demonstrate several common capabilities: robust clinical validation strategies that produce peer-reviewed evidence, transparent algorithm performance reporting that supports clinician trust, and flexible commercial models that accommodate both capital procurement and subscription-based software licensing. Additionally, companies that invest in comprehensive training, local service infrastructure, and collaborative research programs tend to accelerate clinical uptake. Strategic partnerships, joint ventures, and selective acquisitions continue to be the primary mechanisms for filling capability gaps and expanding into adjacent clinical and geographic markets.

Actionable strategic recommendations for technology developers, clinical leaders, and procurement teams to accelerate adoption, manage risk, and unlock value from AI-enabled MRI innovations

Industry leaders should pursue a coordinated set of actions that align technology development, clinical validation, and commercial execution to capture value from AI-enhanced MRI innovations. First, prioritize modular architectures that decouple hardware upgrades from software and algorithmic improvements, enabling continuous feature enhancement without repeated capital expenditure. Coupled with this, establish rigorous clinical evaluation pathways that incorporate multicenter studies and peer-reviewed publication to build clinician confidence and payer recognition.

Second, strengthen supply chain resilience through supplier diversification, regional assembly capabilities, and contractual mechanisms that share tariff and logistics risks. This approach reduces deployment delays and safeguards service continuity. Third, invest in data partnerships and governance frameworks that enable federated learning, while maintaining strict privacy safeguards and traceability for model updates. These investments improve algorithm generalizability and reduce time to clinical readiness.

Fourth, adopt flexible commercial models that combine capital equipment sales with subscription-based analytics and outcome-linked service contracts to align incentives with clinical outcomes and institutional budgets. Fifth, prioritize clinician-centered design and comprehensive training programs that facilitate workflow integration, reduce cognitive load, and foster adoption. Finally, engage early with regulators and payers to clarify evidence requirements and reimbursement pathways, thereby reducing approval timelines and accelerating access to patients. Implementing these recommendations will position organizations to convert technical capabilities into sustainable clinical and commercial impact.

A rigorous mixed-methods research methodology integrating clinician interviews, regulatory analysis, patent landscaping, and evidence triangulation to inform strategic decisions and identify evidence gaps

This research synthesizes insights derived from a structured methodology that combines qualitative engagement with clinical and technical stakeholders, systematic secondary research across scientific literature and regulatory filings, and triangulation through technology and patent landscape analyses. Primary research included in-depth interviews with clinicians, radiology technologists, hospital procurement officials, systems integrators, and R&D leaders to surface real-world deployment challenges, clinical priorities, and procurement considerations. These conversations informed use-case prioritization and validation criteria for algorithm performance and service expectations.

Secondary sources encompassed peer-reviewed journals, clinical trial registries, public regulatory documents, company regulatory clearances and product specifications, and white papers from academic consortia. Patent and technology landscape analysis identified emergent architectures in reconstruction, sequence design, and AI-enabled analytics, providing insight into innovation trajectories. Data synthesis employed methodical triangulation to reconcile divergent viewpoints and to highlight consensus themes, while sensitivity checks identified areas where evidence was nascent or evolving.

Limitations of the methodology include potential sampling bias in primary interviews and the rapidly changing nature of AI model performance as new clinical evidence emerges. To mitigate these limitations, the research applied cross-validation across multiple respondent types, prioritized peer-reviewed clinical outcomes where available, and documented uncertainty where evidence remained preliminary. The result is a balanced, multidisciplinary evidence base that supports strategic decision-making while acknowledging areas for ongoing monitoring and follow-up validation.

A concise conclusion synthesizing technological, clinical, and operational imperatives that determine who succeeds in deploying AI-enabled MRI solutions at scale

In summary, AI-enhanced MRI is transitioning from demonstration projects to integrated clinical tools that improve diagnostic workflows, support quantification, and enable more patient-centric imaging protocols. Technological advances in reconstruction, algorithmic analytics, and system design are converging with shifting care delivery models to create meaningful clinical and operational benefits. At the same time, structural pressures such as trade policies, supply chain reconfiguration, and evolving regulatory expectations are shaping how solutions are designed, sourced, and deployed.

The path to sustainable value lies in aligning product architectures with clinical workflows, investing in robust multicenter validation, and building resilient supply and service networks that accommodate regional regulatory and procurement differences. Vendors and health systems that adopt modular update strategies, transparent validation practices, and collaborative partnerships will reduce friction and accelerate the translation of innovation into improved patient outcomes. Looking ahead, continuous learning systems, federated data approaches, and clinician-centered interfaces will be pivotal in ensuring that AI-enhanced MRI delivers reproducible, interpretable, and equitable diagnostic value across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI-Enhanced MRI System Market, by Component

  • 8.1. Hardware
    • 8.1.1. Gradient Systems
    • 8.1.2. Magnet Systems
  • 8.2. Services
    • 8.2.1. Installation Services
    • 8.2.2. Maintenance Services
  • 8.3. Software
    • 8.3.1. Data Management Solutions
    • 8.3.2. Imaging Software

9. AI-Enhanced MRI System Market, by MRI System Type

  • 9.1. Closed MRI
  • 9.2. Open MRI

10. AI-Enhanced MRI System Market, by Application

  • 10.1. Clinical Trials
  • 10.2. Diagnostic Imaging
    • 10.2.1. Cardiology
    • 10.2.2. Neurology
    • 10.2.3. Oncology
  • 10.3. Research

11. AI-Enhanced MRI System Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Individual Radiologists
  • 11.4. Research Institutes

12. AI-Enhanced MRI System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. AI-Enhanced MRI System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. AI-Enhanced MRI System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States AI-Enhanced MRI System Market

16. China AI-Enhanced MRI System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arterys Inc.
  • 17.6. Blackford Analysis LTD
  • 17.7. Canon Medical Systems Corporation
  • 17.8. Cerebriu A/S
  • 17.9. CityClinic Vietnam Limited
  • 17.10. CureMetrix
  • 17.11. EnvoyAI Inc.
  • 17.12. Esaote SpA
  • 17.13. Ezra AI, Inc.
  • 17.14. Fujifilm Holdings Corporation
  • 17.15. GE HealthCare Technologies Inc.
  • 17.16. HeartVista, Inc.
  • 17.17. Hitachi Medical Corporation
  • 17.18. Hyperfine, Inc.
  • 17.19. Koninklijke Philips N.V.,
  • 17.20. Medic Vision Imaging Solutions
  • 17.21. Neusoft Medical Systems
  • 17.22. Nuance Communications
  • 17.23. Perspectum Ltd
  • 17.24. Samsung Electronics Co.Ltd
  • 17.25. Siemens Healthineers AG
  • 17.26. Subtle Medical, Inc.
  • 17.27. United Imaging Healthcare Co., Ltd
  • 17.28. Volpara Solutions
  • 17.29. Zebra Medical Vision, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI-ENHANCED MRI SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GRADIENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GRADIENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GRADIENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAGNET SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAGNET SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAGNET SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INSTALLATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INSTALLATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INSTALLATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLOSED MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLOSED MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLOSED MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY OPEN MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY OPEN MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY OPEN MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INDIVIDUAL RADIOLOGISTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INDIVIDUAL RADIOLOGISTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY INDIVIDUAL RADIOLOGISTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 159. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 164. GCC AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 186. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 191. G7 AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 195. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 200. NATO AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY MRI SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA AI-ENHANCED MRI SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)